Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Marianne De Backer, Ph.D., is the CEO of Vir Biotechnology, Inc., a biotechnology company dedicated to developing novel therapies for infectious diseases and cancer. Dr. De Backers leadership is marked by her commitment to advancing innovative treatments through cutting-edge research and development. With extensive experience in biotechnology and strategic management, she has been instrumental in guiding Vir Biotechnology through key stages of drug development and clinical trials. Her vision focuses on harnessing advanced technologies to address significant global health challenges and improve patient outcomes. Under her leadership, Vir Biotechnology continues to make significant strides in the development of transformative therapies for complex diseases.
